Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Change in Account Payables (2020 - 2022)

Historic Change in Account Payables for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q4 2022 value amounting to $1.4 million.

  • Atea Pharmaceuticals' Change in Account Payables rose 10811.62% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$2.0 million, marking a year-over-year decrease of 11927.3%. This contributed to the annual value of $206000.0 for FY2024, which is 8788.95% down from last year.
  • Per Atea Pharmaceuticals' latest filing, its Change in Account Payables stood at $1.4 million for Q4 2022, which was up 10811.62% from -$12.8 million recorded in Q3 2022.
  • In the past 5 years, Atea Pharmaceuticals' Change in Account Payables registered a high of $12.7 million during Q2 2021, and its lowest value of -$17.7 million during Q4 2021.
  • Its 3-year average for Change in Account Payables is $651500.0, with a median of $1.2 million in 2020.
  • Data for Atea Pharmaceuticals' Change in Account Payables shows a peak YoY increase of 258800.0% (in 2021) and a maximum YoY decrease of 32269.57% (in 2021) over the last 5 years.
  • Atea Pharmaceuticals' Change in Account Payables (Quarter) stood at -$4.2 million in 2020, then plummeted by 322.7% to -$17.7 million in 2021, then skyrocketed by 108.12% to $1.4 million in 2022.
  • Its Change in Account Payables stands at $1.4 million for Q4 2022, versus -$12.8 million for Q3 2022 and $10.2 million for Q2 2022.